Rearming the body’s immune system to fight cancer
We’re developing more precise and more accessible treatment alternatives for patients with solid cancers
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.
Some of our partners
Latest news
‘Off-the-Shelf’ Immunotherapy for Ovarian Cancer
By Christine Filippis / June 11, 2021
Cartherics' CEO Alan Trounson speaks at the BIO KOREA 2021 International Convention By Leigh Dayton 11 June 2021 Alan Trounson...
Read More
New Cancer Therapy Brings Hope
By Christine Filippis / June 7, 2021
Battling blood cancer in my 20s, I put my faith in a clinical trial for a promising new CAR-T treatment....
Read More
Cancer survivor Heather Hawkins was devastated by news that early detection of ovarian cancer doesn’t save lives …..
By Christine Filippis / May 24, 2021
But she has “unshakeable hope” that Cartherics’ innovative treatments promise an alternative path By Heather Hawkins 24 May 2021 Ovarian...
Read More
